Page last updated: 2024-12-07
5-(bromomethyl)fluorescein
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
5-(bromomethyl)fluorescein: used to label the Ca(2+) Mg(2+)-ATPase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 132858 |
SCHEMBL ID | 337558 |
MeSH ID | M0217530 |
Synonyms (13)
Synonym |
---|
spiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one, 5-(bromomethyl)-3',6'-dihydroxy- |
5-(bromomethyl)fluorescein |
148942-72-7 |
5-bmf |
6-(bromomethyl)-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one |
FT-0619697 |
AKOS025294551 |
SCHEMBL337558 |
J-100041 |
DTXSID90164145 |
5-(bromomethyl)fluorescein, bioreagent, suitable for fluorescence, >=95% (sum of tautomers, gc) |
spiro[isobenzofuran-1(3h),9'-[9h]xanthen]-3-one, 5-(bromomethyl)-3',6'-dihydroxy- |
5-(bromomethyl)-3',6'-dihydroxy-3h-spiro[isobenzofuran-1,9'-xanthen]-3-one |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |